NCT07476677 2026-03-17ANDARPCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting60 enrolled
NCT06660862 2026-01-08Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.University of ChicagoPhase 4 Not yet recruiting80 enrolled